Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori

FEMS Microbiology Letters

Volumn 142, Issue 1, 1996, Pages 37-42

  Debets Ossenkopp, Y J ^a   Sparrius, M ^b   Kusters, J G ^b   Kolkman, J J ^a   Vandenbroucke Grauls, C M J E ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

23S rRNA mutation; Antibiotic resistance; Erythromycin resistance methylase; Macrolide antibiotic

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; METHYLTRANSFERASE; MIKAMYCIN B; RANITIDINE; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; DOSE RESPONSE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PEPTIC ULCER; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0030586714     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1097(96)00239-X     Document Type: Article

References (17)

1. [1] Marshall, B.J., Warren, J.R., Blincow, E.D., Philips, M., Goodwin, C.S., Murray, R., Blackbourn, S.J., Waters, T.E. and Sanderson, C.R. (1988) Prospective double-blind trial of duodenal relapse after eradication of Campylobacter pylori. Lancet. ii, 1437-1441.
2. [2] Walsh, J.H. and Peterson, W.L. (1995) The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 333, 984-991.
3. [3] Vester, B. and Garrett. R.A. (1987) A plasmid-coded and site-directed mutation in Escherichia coli 23S. RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochemistry 69, 891-900.
4. [4] Arthur, M., Brisson-Noël, A. and Courvalin, P. (1987) Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. J. Antimicrobiol. Chemother. 20, 783-802.
5. [5] Queiroz, D.M.M., Mendes, E.N.M. and Rocha, G.A. (1987) Indicator medium for isolation of Campylobacter pylori. J. Clin. Microbiol. 25, 2378-2379.
6. [6] Glupczynski, Y., Labbé, M., Hansen, W.. Crokaert, F. and Yourassowsky, E. (1991) Evaluation of the E Test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J. Clin. Microbiol. 29, 2072-2075.
7. [7] Ausubel, F.M., Brent, R., Kingston, R.E., Moore. D.D., Seidman, J.G., Smith, J.A. and Struhl, K.S. (1989) Current Protocols in Molecular Biology. Greene Publ. and Wiley-Interscience. New York.
8. [8] Go, M.F., Chan, K.Y., Versalovic, J., Koeuth, T., Graham, D.Y. and Lupski, J.R. (1995) Cluster analysis of Helicobacter pylori genomic DNA fingerprints suggests gastroduodenal disease-specific associations. Scand. J. Gastroenterol. 30, 640-646.
9. [9] Arthur, M., Molinas, C., Mabilat, C. and Courvalin, P. (1990) Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob. Agents Chemother. 34, 2024-2026.
10. [10] Hiratsuka, K. (1995) Helicobacter pylori 23S and 5S ribosomal RNA genes, complete sequence. Genbank accession U27270.
11. [11] Van Steenbergen, M.T.J., Colloms, S.D., Hermans, P.W.M., de Graaff, J. and Plasterk, R.H.A. (1995) Genomic DNA fingerprinting by restriction fragment end labeling. Proc. Natl. Acad. Sci. USA 92, 5572-5576.
12. [12] Debets-Ossenkopp, Y.J., Namavar, F. and Maclaren, D.M. (1995) Effect of an acidic environment on the susceptibility of Helicobacter pylori to Trospectomycin and other antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 14, 353-355.
13. [13] Moazed, D. and Noller, H.F. (1987) Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69, 879-884.
14. [14] Meier, A., Kirschner, P., Springer, B., Steingrube, V.A, Brown, B.A., Wallace Jr., R.J. and Böttger, E.C. (1994) Identification of mutations in 23S rRNA gene of clarithromycin resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38, 381-384.
15. [15] Nash, K.A. and Inderlied, C.B. (1995) Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob. Agents Chemother. 39, 2625-2630.
16. [16] Versalovic, J., Shortndge, D., Kibler, K., Griffie, M.V., Beyer, J., Flamm, R.K., Tanaka, S.K., Graham, D.Y. and Go, M.F. (1996) Mutations in 23S rRNA are associated with clarithromycin resistance in Helicohacter pylori. Antimicrob. Agents Chemother, 40, 477-480.
17. [17] Xia, H., Buckley, M., Keane, C.T. and O'Morain, C.A. (1996) Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspectic patients and stability in vitro. J. Antimicrob. Chemother. 37, 473-481.